BranchLab is an AI-native healthcare technology company, founded in 2024. The firm positions itself as the leading provider of privacy-first, outcome-based advertising solutions for the healthcare industry. Its work sits at the intersection of deep learning, predictive modeling, and healthcare data.
The company's flagship product is Pathwai™, a platform designed for pharmaceutical brands, healthcare marketers, agencies, and media partners. It enables these entities to design, activate, and measure audiences optimized for real-world health outcomes, such as prescriptions, diagnoses, or healthcare visits.
BranchLab has raised $26 million in Series A funding. Its operations are based in New York, Colorado, and San Francisco. The company's solutions serve clients across several sectors, including healthcare, pharma, government, and retail.
